Why Moderna's betting big on gene editing

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


A scientist at Moderna works on research at the biotech's R&D hub in Norwood, Massachusetts
A scientist at Moderna works on research at the biotech's R&D hub in Norwood, Massachusetts
The scientist who helped Moderna became a vaccine powerhouse told us why he thinks gene editing is the future for the $91 billion biotech

Read more>>


Moderna vaccine
Moderna has soared over the last year on the back of its coronavirus vaccine.
2 states offer COVID-19 booster shots to all adults, bypassing CDC guidance

Dive in>>


People wearing masks queue in Austria
People waiting for a mass Covid-19 testing in Vienna, Austria, Friday, Dec 4, 2020.
An Austrian province is preparing a COVID-19 lockdown for unvaccinated people only, saying the vaccinated shouldn't have to 'lose their freedom'

Get the full story>>


More stories we're reading:


-Leah

Read the original article on Business Insider


from Business Insider https://ift.tt/3cbjNYQ

No comments

Powered by Blogger.